Roivant Sciences Ltd (NASDAQ:ROIV – Get Rating)’s stock price reached a new 52-week low on Friday . The company traded as low as $4.75 and last traded at $4.76, with a volume of 12427 shares changing hands. The stock had previously closed at $5.11. A number of equities analysts recently weighed in on ROIV shares. […]
Roivant Sciences Ltd (NASDAQ:ROIV – Get Rating) CEO Matthew Gline sold 82,006 shares of the stock in a transaction on Friday, March 18th. The stock was sold at an average price of $5.13, for a total transaction of $420,690.78. The transaction was disclosed in a document filed with the SEC, which is available at this […]
Roivant Sciences Ltd (NASDAQ:ROIV – Get Rating)’s stock price dropped 3.3% during trading on Wednesday . The stock traded as low as $4.93 and last traded at $5.02. Approximately 9,521 shares changed hands during trading, a decline of 97% from the average daily volume of 310,661 shares. The stock had previously closed at $5.19. Several […]
Roivant Sciences Ltd (NASDAQ:ROIV – Get Rating) has been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and seven have issued a buy recommendation on the company. The average 12-month price target among brokers that […]